
Licorice in the Treatment of Acne Vulgaris and Postinflammatory Hyperpigmentation: A Review
Author(s) -
Kosar Raoufinejad,
Mehdi Rajabi,
Golnaz Sarafian
Publication year - 2021
Publication title -
journal of pharmaceutical care
Language(s) - English
Resource type - Journals
eISSN - 2322-4630
pISSN - 2322-4509
DOI - 10.18502/jpc.v8i4.5242
Subject(s) - glycyrrhiza , acne , medicine , dermatology , clinical trial , pharmacology , hyperpigmentation , safety profile , traditional medicine , adverse effect , pathology , alternative medicine
Clinical advantages of licorice (Glycyrrhiza spp.) have been investigated for several years. It has been traditionally used for a variety of disorders. Different constituents with various characteristics have been isolated from Glycyrrhiza spp. extracts. This review aimed to summarize the current knowledge on the pharmacological efficacy and safety of licorice extract constituents to treat the pathophysiology of acne vulgaris (AV) and the associated postinflammatory hyperpigmentation (PIH). Anti-androgenic, antimicrobial, anti-inflammatory, antioxidant, depigmenting, and skinturnover-accelerating properties have been identified for licorice extract which could be effective against AV and PIH through multiple pharmacological mechanisms. The active compounds responsible for these pharmacological activities, molecular mechanisms, safety profile, as well as the in vitro, in vivo, animal, and clinical studies are discussed. Licorice extract possesses broadspectrum activity and could be considered as an effective and safe option in the treatment of AV and its associated PIH. However, evidence-based clinical trials are required to prove its efficacy as well as safety. We hope this paper can provide new insights for further studies, particularly large controlled clinical trials.